Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vero cell-derived whole virion influenza vaccine lot comparison versus egg-derived influenza vaccine (2004/2005 season)
2004-001374-34Phase 2Completed
- Sponsor
- Baxter International Inc.
- Start
- Nov 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Fluzone Trivalent in influenza (4 arms), sponsored by Baxter International Inc. Primary endpoints: Primary immunogenicity endpoint, Lot-to-lot immune response comparison and 1 more. Started Nov 2004; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2004-001374-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001374-34.